Shield Therapeutics Share Discussion Threads

[nobbygnome] 13/8/2020 11:12

Mostly buys this morning (despite what the trade log says) and the bid is edging up. Looking promising. I am watching like a hawk with my finger hovering over the buy button to get more.

[nobbygnome] 13/8/2020 10:37

Another 10k for me and I will be looking to buy more. I just think this is a complete open goal now with Tim's confident comments about a deal the other day.

All IMHO and DYOR.....

[nobbygnome] 13/8/2020 10:34

I've given it a lot of thought and it's time to go big here.....

[bobaxe1] 12/8/2020 09:44

Like the sound of a massive upside nobby. Will be adding before the end of the week. Atb

[nobbygnome] 12/8/2020 09:16

MMs caught and short....

[nobbygnome] 12/8/2020 07:35

All buys this morning. About to pop IMHO if there is any further volume of buying....

[frrinvest] 11/8/2020 21:49

yes very good interview and very confident of next steps. I can see the share price 250p+ on deal announcement. I would buy more if I had the dosh! As a guess deal by eof Aug.2020? imho.

[peachie 74] 11/8/2020 17:50

He also states they will get approval in China which is a massive market

[nobbygnome] 11/8/2020 17:06

With Tim's confidence in both interviews this is a screaming buy IMHO. As he says there is substantial upside when we get the deal....

[nobbygnome] 11/8/2020 16:43

Good interview with Tim although he is a bit hesitant in his delivery as usual. Seems confident about signing a US deal....

In fact there are 2 interviews there for the price of one as there is also a Proactive one as well.

[nobbygnome] 11/8/2020 15:13

The 5k trade at 117 is most definitely a buy 😜....

[itshenderz] 11/8/2020 11:29

Flushed out a few bed wetters Friday and yesterday. Real gains % on highly anticipated US deal. Proactive Investors interview yesterday put myself a lot of my initial queries at ease.

[peachie 74] 11/8/2020 10:26

Yes. Just shows with this share how easy it can swing and catch people out. It drops quick , punters get scared and sell.
Next day up she goes and you can’t get back in anywhere near what you sold at.

[nobbygnome] 11/8/2020 10:15

Tried to get 5k when the price was 115. There was nothing on the RSP so my broker went straight to the MMs. Both MMs on the offer had people queuing up to buy and both sold 2500 and then moved the price. So I was left without any but it just goes to show there is plenty of appetite for this stock at the moment.

I will wait and see what develops before trying to buy again....

[ny boy] 11/8/2020 09:25

Done all my adding, using spare funds to pile into a few other recovery plays, markets bullish this week.

This one, just hold and await news flow

[peachie 74] 11/8/2020 09:16

This rises quick and falls quick.
Not many shares about in PI hands.
The PIs with any sense should hang on imo. Easy to get disheartened with no news. But you have to believe in the facts of this drug.

[adman50] 11/8/2020 09:01

Nice to see some vertical movement.

[tickboo] 11/8/2020 08:27

End of summer is Sept 21st or so if memory serves.

[frrinvest] 11/8/2020 08:16

Must be getting close to annoucement as we head towards end of summer. This was the feedback from CEO a a few months ago. Fingers crossed.

[lovewinshatelosses] 10/8/2020 12:26

Disappointing to see us sinking back down again. I had hoped to see a new floor after that rise last week. Oh well, of no consequence really as real deal news is what we are waiting for!

[daveboy1] 09/8/2020 08:30

Nobby - this is the quote I saw from the email I received from Alice Woodings at Shield on Friday, so all good I’d say... GLA :-
Edison’s forecasts remain unchanged but it states that the results ‘will have positive implications for health economic outcomes, pricing strategies and partnering opportunities’.

[nobbygnome] 08/8/2020 15:57

>> borromini

Done....but don't forget it can be reinstated at a moment's notice 😜.....

[nobbygnome] 08/8/2020 15:55

Well our thoughts turn again back to the US licensing deal. I can't make up my mind whether the reanalysing of the data makes a US deal easier or not as the HtH data wasn't in the US file because of timing. Although the reps couldn't talk about the data MSLs probably can so on balance I think it does add extra value for a US company?

[1gw] 07/8/2020 11:10

Joined you yesterday after the rns. Looks good to me in terms of the economic case. And I think can't have been far outside the 20% limit for the "non-inferiority" primary endpoint test.

[nashwan123] 07/8/2020 10:42

My reading of the data is that the treatment results are not significantly better than the IV option but much cheaper.